|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues | ||||
| Cost of revenues | ||||
| Gross profit | ||||
| Research and development expenses | ||||
| Sales and marketing expenses | ||||
| General and administrative expenses | ||||
| Operating loss | ||||
| Finance expenses (income), net | ||||
| Net loss and comprehensive loss | ||||
| Basic and diluted net loss per share (in Dollars per share) | ||||
| Diluted net loss per share (in Dollars per share) | ||||
| Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in Shares) | ||||
| Weighted average number of shares outstanding used in computing diluted net loss per share (in Shares) | ||||
Loading...
